US 11230541
Heterocyclic compound
granted A61KA61K31/4162A61K31/4184
Quick answer
US patent 11230541 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/4162, A61K31/4184, A61K31/4192, A61K31/4439